Bellerophon Therapeutics Inc – Underwriting Agreements – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Underwriting Agreements Filter

from SC 13D ~5 pages Form of Subscription Agreement

from 8-K 32 pages 1,923,077 Shares of Common Stock Bellerophon Therapeutics, Inc. Underwriting Agreement

from 8-K 8 pages Exhibit 1.1

from 8-K 33 pages Exhibit 1.1 10,000,000 Shares of Common Stock Bellerophon Therapeutics, Inc. Underwriting Agreement

from 8-K 3 pages Bellerophon Therapeutics Announces Enrollment Exceeds 100 Patients in Phase 3 Inovation-1 Study Evaluating Inopulse® for Treatment of Pulmonary Arterial Hypertension

from 8-K 39 pages Bellerophon Therapeutics, Inc. Common Stock

from S-1/A 40 pages Bellerophon Therapeutics, Inc. (A Delaware Corporation) [—] Shares of Common Stock Form of Underwriting Agreement Dated: [—], 2015 Bellerophon Therapeutics, Inc. (A Delaware Corporation) [—] Shares of Common Stock Underwriting Agreement